新型Pt(IV) 复合体OAP2诱导STING激活和通过线粒体膜重塑来进行协同化疗-免疫疗法来诱导激光灭亡
Renming Fan1,2, Ruizhuo Lin1,2, Shuo Zhang3
1Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China.
Acta pharmaceutica Sinica. B
|April 4, 2024
概括
一种新型药物OAP2触发了线粒体膜重塑,释放了线粒体DNA (mtDNA). 这激活了抗瘤免疫和细胞死亡,为癌症治疗提供了新的策略.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 线粒体膜重塑释放线粒体DNA (mtDNA),激活免疫反应.
- 线粒体膜重塑在瘤中的作用尚不清楚.
研究的目的:
- 为了研究一种新型Pt(IV) 复合体OAP2的抗瘤作用,OAP2由氧沙和乙氨基组成.
- 探索OAP2在调节线粒体膜重塑和激活抗瘤免疫力的机制.
主要方法:
- 设计和合成了新的Pt(IV) 复合物OAP2.
- 研究了OAP2对核DNA损伤,线粒体Sam50表达和mtDNA释放的影响.
- 评估了OAP2对cGAS-STING通路,热和抗瘤免疫反应的影响.
主要成果:
- OAP2诱导核DNA损伤并降低线粒体Sam50的调节,促进膜重塑和mtDNA分泌.
- OAP2激活了细胞内cGAS-STING通路和气体皮质胺-D介导的烧.
- OAP2增强树突细胞成熟和细胞毒性T细胞活性,抑制瘤的进展.
结论:
- OAP2是第一个针对线粒体膜重塑的小分子抑制剂,用于活性免疫疗法.
- 通过协同激活免疫反应和细胞死亡,OAP2提供了一种针对器官向的抗瘤疗法的新策略.
相关概念视频
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907
The Extrinsic Apoptotic Pathway
6.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K


